Jerry L. Nadler, MD, FACP, FAHA, FACE, is Professor and the Harry H. Mansbach Endowed Chair in Internal Medicine and Vice Dean of Research. Dr. Nadler had been Director of the Strelitz Diabetes Center (SDC) at EVMS but he stepped down from that post in the fall of 2013 to devote time to his new role overseeing research at EVMS. He remains a key member of the SDC team.
Dr. Nadler has been a member of a Special Advisory Committee on Type I Diabetes with the Director of the National Institutes of Health (NIH). He has research funding from the NIH as well as the Juvenile Diabetes Foundation. Dr. Nadler has been a standing member of the ADA, American Heart, and NIH grant review committees. He has over 190 peer-reviewed publications in major scientific journals in the field. He also has been an invited speaker at the American Diabetes Association, Australian Diabetes Association, World Diabetes Congress and International Meetings of the European Association of Diabetes.
His primary interest is the role of lipid and immune inflammatory pathways leading to pancreatic beta cell damage and better understanding of the cardiovascular complications of diabetes and obesity. He is also very active in developing new therapies to help prevent inflammatory damage to pancreatic islets and stopping the complications of diabetes. He holds 11 patents and has been involved in biotech start-up companies.
One of the genes he is working on is called the 12-Lipoxygenase gene. This gene has been associated with the heart, kidney and nerve damage complications of diabetes. Dr. Nadler is now helping to develop new medications that can halt the damaging effects of this pathway. He also is studying new medications that can halt the inflammatory damage to pancreatic islets and reduce atherosclerosis.
Prior to joining EVMS in 2008, Dr. Nadler was Chief of Endocrinology and Metabolism at the University of Virginia, Co-Director of the Diabetes and Hormone Center of Excellence and Associate Director of the school’s NIH-funded Diabetes Endocrinology Research Center.
Dr. Nadler received his medical degree from the University of Miami, followed by specialized training at the University of Southern California. In 2016, he was named Outstanding Scientist in Virginia. He is a member of the Planning and Oversight Committee of the Virginia Biosciences Health Research Corporation.